A method for extracting bibenzyl compounds and application thereof
The bibenzyl compounds in Dendrobium officinale were extracted through multi-step chromatography separation, which solved the problem of unclear gastric mucosa protection effect, achieved efficient enrichment and purity improvement of the compounds, and provided a new drug for the treatment of gastrointestinal diseases. Effective substance.
Patent Information
- Application Number
- CN202211612719.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-14
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2042-12-14
AI Technical Summary
The prior art has not yet determined whether the Binbenzyl compound of Dendrobium officinale extract is a pharmacokinetic substance for gastric mucosa protection, and its extraction method has not been effectively enriched and improved purity and stability.
Using the dried stems of Dendrobium officinale for water extraction and ethanol extraction, combined with macroporous adsorption resin column and silica gel column chromatography separation, gradient elution and purification, 7 bibenzyl compounds were successfully extracted, and improved by multi-step chromatography separation. Its purity and stability.
It was first verified that bibenzyl compounds have gastric mucosal protective effects, successfully enriched and improved their purity and stability, providing a new pharmacokinetic substance for the treatment of gastrointestinal diseases of Dendrobium officinale.
Smart Images

Figure FHA0000007879730000011 
Figure FHA0000007879730000012 
Figure GHA0000007879740000011
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of traditional Chinese medicine preparation, and specifically relates to a method for extracting bibenzyl compounds from Dendrobium officinale and application thereof. Background Art
[0002] Dendrobium officinale Kimura et Migo, also known as black knot grass and iron orchid, is an epiphytic herb of the genus Dendrobium in the Orchidaceae family. It is mainly distributed in the southwest and southern provinces of my country. It tastes sweet and is slightly cold in nature. It enters the stomach and kidney meridians. The dried stems are often used as medicine. It is beneficial to the stomach to produce fluid, nourish yin and clear away heat. It is often used for febrile disease, fluid damage, dry mouth and thirst, insufficient stomach yin, poor appetite and retching, persistent fever due to febrile disease, yin deficiency and excessive fire, bone steaming and fatigue, blurred vision, weak tendons and bones, etc. The medical classics of all dynasties have regarded Dendrobium officinale as the "top grade of medicine", and the Taoist medical classic "Daozang" even lists Dendrobium officinale as the first of the "Nine Immortal Grasses". According to literature reports, the chemical components of Dendrobium officinale mainly include polysaccharides, bibenzyls, phenanthrene, lignans, flavonoids, phenylpropanoids, etc. Modern pharmacological studies have shown that the bibenzyl compounds in Dendrobium officinale have anti-tumor, neuroprotective, antioxidant and gastrointestinal motility-promoting effects.
[0003] However, it is still unclear whether the main component of the Dendrobium officinale extract, the bibenzyl compounds, is the active substance for the gastric mucosal protective effect of Dendrobium officinale. Based on this, it is urgent to find a new extraction method to extract active compounds with gastric mucosal protective effect. Summary of the invention
[0004] The purpose of the present invention is to provide a method for preparing bibenzyl compounds in Dendrobium officinale, so as to extract active compounds with gastric mucosal protective effect, effectively enrich them, and improve purity and stability.
[0005] In order to solve the above problems, the present invention provides a method for preparing bibenzyl compounds in Dendrobium officinale, comprising the following steps:
[0006] S1. Cut the dried stems of Dendrobium officinale into segments, add water, heat and reflux for extraction, and concentrate under reduced pressure to obtain a water extract. The residue obtained after the water extraction is heated and refluxed with 95% ethanol for alcohol extraction, and concentrated under reduced pressure to obtain an alcohol extract; the water extract is first separated by macroporous adsorption resin column chromatography, gradient eluted with an ethanol-water system, and then separated by silica gel column chromatography, gradient eluted with a dichloromethane-methanol system, and purified to obtain any one of the following bibenzyl compounds:
[0007]
[0008]
[0009] S2. Separate the alcohol extract by silica gel column chromatography, elute with cyclohexane-ethyl acetate and dichloromethane-methanol gradient, and purify to obtain any one of the following bibenzyl compounds:
[0010]
[0011] Among them, the names of compounds 1-7 are dendrocandin O, dendrocandin N, 3,4'-dihydroxy-5-methoxybibenzyl, 3,3'-dihydroxy-5-methoxybibenzyl, 3-hydroxy-4',5-dimethoxybibenzyl, 3-hydroxy-3',4',5-trimethoxybibenzyl, and 4'-hydroxy-3,3',4,5-tetramethoxybibenzyl, respectively.
[0012] The specific water extraction method described in step S1 includes: the solid-liquid ratio of Dendrobium officinale stem to water is (0.9-1.1) g: (9-11) mL, the number of reflux extractions is at least 2 times, and the time of each reflux extraction is 2-3 hours; the solid-liquid ratio of Dendrobium officinale stem residue to ethanol-water solution in the alcohol extraction is (0.9-1.1) g: (9-11) mL; wherein the ethanol-water solution is preferably an ethanol-water solution with a volume percentage of 95% ethanol, and the reflux extraction is heated again, the number of reflux extractions is at least 2 times, and the time of each reflux extraction is 2-3 hours.
[0013] Preferably, the method of gradient elution with an ethanol-water system in step S1 comprises gradient elution with an ethanol-water system having a gradient concentration of 0:100, 30:70, 50:50, 70:30, and 95:5, collecting an eluent having an ethanol-water system concentration of 70:30, i.e., DO1-D, and an eluent having an ethanol-water system concentration of 95:5, i.e., DO1-E; the method of gradient elution with a dichloromethane-methanol system in step S1 comprises: O1-D and DO1-E were gradient eluted with a dichloromethane-methanol system with volume ratios of 100:0, 99:1, 98:2, 97:3, 95:5, 93:7, 9:1, 8:2, 7:3, 1:1, and 0:100, respectively, and the eluates with volume ratios of 99:1, i.e., DO1-D3, 98:2, i.e., DO1-D4, 100:0, i.e., DO1-E2, and 99:1, i.e., DO1-E4, were collected respectively.
[0014] Preferably, the purification method in step S1 comprises separating and purifying DO1-D3, DO1-D4, DO1-E2, and DO1-E4 by Sephadex LH-20 column chromatography, isocratically eluting with a dichloromethane-methanol system with a volume ratio of 1:1 to obtain fractions DO1-D31 to DO1-D33, DO1-D41 to DO1-D42, DO1-E21 to DO1-E23, and DO1-E41 to DO1-E43; then separating by ODS column chromatography, gradient eluting with a methanol-water system, and then separating by high performance liquid chromatography. DO1-D33 is separated by ODS column chromatography and gradient eluted with a methanol-water system to obtain DO1-D331~DO1-D335, in which the volume percentage of methanol is 30~100%; DO1-D42 is separated by ODS column chromatography and gradient eluted with a methanol-water system to obtain DO1-D421~DO1-D427; in the methanol-water system, the volume percentage of methanol is 20-100%; DO1-E23 is separated by ODS column chromatography and gradient eluted with a methanol-water system to obtain DO1-E231~DO1-E236; in the methanol-water system, the volume percentage of methanol is 50-100%; DO1-E42 is separated by ODS column chromatography and gradient eluted with a methanol-water system to obtain DO1-E421~DO1-E426; in the methanol-water system, the volume percentage of methanol is 40-100%.
[0015] Preferably, the method of gradient elution with a methanol-water system comprises gradient elution in the order of 20%, 30%, 40%, 50%, 60%, 70%, and 100% by volume of the methanol-water system;
[0016] DO1-D3 was dissolved in a 40% by volume methanol-water solution to obtain DO1-D332, and preparative liquid chromatography was performed at an ultraviolet detection wavelength of 240 nm using a 50% by volume methanol-water solution as an eluent at a flow rate of 4 mL / min, and the chromatographic peak was collected for 23 min to obtain a compound of formula (4);
[0017] DO1-D4 was dissolved in a 60% by volume methanol-water solution to obtain DO1-D425. The preparative liquid chromatography was performed at an ultraviolet detection wavelength of 220 nm using a 45% by volume methanol-water solution as an eluent at a flow rate of 4 mL / min. The chromatographic peak was collected at 37 min to obtain a compound of formula (2);
[0018] DO1-E2 was dissolved in a 70% by volume methanol-water solution to obtain DO1-E233. The preparative liquid chromatography was performed at an ultraviolet detection wavelength of 220 nm using a 55% by volume methanol-water solution as the eluent at a flow rate of 4 mL / min. The chromatographic peak was collected at 41 min to obtain a compound of formula (5);
[0019] DO1-E4 was dissolved in a 40% by volume methanol-water solution to obtain DO1-E421. The preparative liquid chromatography was performed at an ultraviolet detection wavelength of 240 nm using a 50% by volume methanol-water solution as an eluent at a flow rate of 4 mL / min. The chromatographic peak was collected for 22 minutes to obtain a compound of formula (3);
[0020] DO1-E4 was dissolved in a 50% by volume methanol-water solution to obtain DO1-E422. The preparative liquid chromatography was performed at an ultraviolet detection wavelength of 240 nm using a 60% by volume methanol-water solution as an eluent at a flow rate of 4 mL / min. The chromatographic peak was collected for 20 min to obtain a compound of formula (1);
[0021] DO1-E4 was dissolved in a 60% by volume methanol-water solution to obtain DO1-E423. The HPLC preparation was carried out at an ultraviolet detection wavelength of 240 nm using a 55% by volume methanol-water solution as the eluent at a flow rate of 4 mL / min. The chromatographic peak was collected at 43 min to obtain the compound of formula (6).
[0022] Preferably, in step S2, the volume ratio of cyclohexane-ethyl acetate is 100:0, 96:4, 9:1, 85:15, 8:2, 7:3, 6:4, 1:1; the volume ratio of dichloromethane-methanol is 93:7, 9:1, 85:15, 8:2, 7:3, 6:4, 1:1, 0:100, and the eluate with a dichloromethane-methanol volume ratio of 9:1 is collected, i.e., DO2-C.
[0023] Preferably, the purification method described in step S2 includes separating and purifying DO2-C by Sephadex LH-20 column chromatography, isocratically eluting with a dichloromethane-methanol system with a volume ratio of 1:1; then separating by silica gel column chromatography, gradient eluting with a cyclohexane-acetone system, then separating by ODS column chromatography, gradient eluting with a methanol-water system, and then separating by high performance liquid chromatography.
[0024] Preferably, the method of gradient elution with a cyclohexane-acetone system comprises performing gradient elution in a cyclohexane-acetone system volume ratio of 97:3, 95:5, 93:7, 9:1, 85:15, and 0:100, and collecting an eluate with a cyclohexane-acetone volume ratio of 93:7, i.e., DO2-C35; the method of gradient elution with a methanol-water system comprises performing gradient elution in a methanol-water volume percentage of 70%, 80%, 90%, and 100%, and obtaining DO2-C351 in a methanol-water solution with a volume percentage of 70%. The volume percentage of cyclohexane-acetone is 97:3-0:100. In the methanol-water system, the volume percentage of methanol is 70-100%.
[0025] Preferably, the HPLC separation method comprises subjecting DO2-C351 to preparative liquid chromatography at an ultraviolet detection wavelength of 210 nm, using a 42% by volume acetonitrile-water solution as an eluent, a flow rate of 4 mL / min, and collecting the chromatographic peak for 33 min to obtain a compound of formula (7).
[0026] The present invention provides the use of bibenzyl compounds prepared by the preparation method described in the above scheme in protecting gastric mucosal epithelial cells.
[0027] Preferably, the application in any of the following:
[0028] A1. For the preparation of drugs for preventing or treating gastrointestinal diseases.
[0029] Compared with the prior art, the present invention has the following beneficial effects:
[0030] The method of the present invention extracts 7 bibenzyl compounds with gastric mucosa protective effect, reports for the first time that bibenzyl compounds have gastric mucosa protective effect, verifies that bibenzyl compounds are one of the medicinal substances of Dendrobium officinale for protecting gastrointestinal function, and the method of the present invention can effectively enrich bibenzyl compounds, and the obtained bibenzyl compounds have the advantages of high purity and good stability.
[0031] The bibenzyl compound prepared by the invention has broad development and application prospects in the fields of medicine and the like, and especially provides broad prospects in the application of preventing or treating gastrointestinal diseases. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 It is a schematic flow diagram of the method of the present invention;
[0033] Figure 2 This is a graph showing the protective effect of compounds 1 to 4 extracted from the present invention on ethanol-induced damage to human gastric mucosal epithelial cells;
[0034] Figure 3The figure shows the protective effect of compounds 5 to 7 extracted from the present invention on ethanol-induced damage to human gastric mucosal epithelial cells. DETAILED DESCRIPTION
[0035] The present invention is further described below in conjunction with specific embodiments, but the present invention is not limited in any way.
[0036] Instruments and reagents:
[0037] Instruments: Bruker AVANCE-400 / 600 superconducting nuclear magnetic resonance instrument (Bruker, Switzerland); Bruker Esquire 2000 low-resolution mass spectrometer (Bruker, Switzerland); Anton Paar MCP 200 fully automatic polarimeter (Anton Paar, Germany); Agilent 1200 analytical high-performance liquid chromatograph (equipped with G1311A HPLC pump and G1315DDAD detector, Agilent, USA); preparative high-performance liquid chromatograph (equipped with LC-6A pump and SPD-20A detector, SHIMADZU, Japan); DZF-6020 vacuum constant temperature drying oven (Shanghai Jinghong Experimental Equipment Co., Ltd.); EYELAN-100 rotary evaporator (Tokyo Rika, Japan); Sartorius AG BT 124S electronic analytical balance (Sartorius Instrument System Co., Ltd., Beijing); Varioskan Flash multi-function microplate reader (Thermo Fisher Scientific, USA) Sientific Corporation).
[0038] Reagents: Sephadex LH-20 (Amersham Biosciences, UK); RP-18 column chromatography filler (50 μm, YMC, Japan); column chromatography silica gel and thin layer chromatography silica gel GF 254 (Qingdao Ocean Chemical Co., Ltd.); chromatographic methanol, chromatographic acetonitrile and other analytical grade (Tianjin Kangkede Technology Co., Ltd.); deuterated methanol (Sigma, USA); FBS fetal bovine serum (Thermo Sientific, USA).
[0039] Example 1 Preparation of water extract and ethanol extract of Dendrobium officinale stem
[0040] The dried stems of Dendrobium candidum (17.9 kg) were cut into segments, and 10 times the amount of water was added to heat and reflux for extraction twice, each time for 2 hours, and the extracts were combined and concentrated under reduced pressure to obtain water extract DO1 (440.0 g). The obtained medicinal residues were extracted with 95% ethanol (90 L) by heating and reflux for extraction twice, each time for 2 hours, and the extracts were combined and concentrated under reduced pressure to obtain alcohol extract DO2 (58.0 g). The aqueous extract DO1 (430.0 g) was suspended with 5 times water and then gradient eluted by Diaion HP-20 macroporous adsorption resin column chromatography with an ethanol-water system as the eluent to obtain five elution fractions: water elution fraction (DO1-A, 280.3 g), 30% ethanol elution fraction (DO1-B, 56.0 g), 50% ethanol elution fraction (DO1-C, 27.0 g), 70% ethanol elution fraction (DO1-D, 7.9 g) and 95% ethanol elution fraction (DO1-E, 5.0 g).
[0041] Example 2 is as shown in the attached Figure 1 The flowchart of the method of the present invention is a method for preparing bibenzyl compounds in Dendrobium officinale, which specifically comprises the following steps:
[0042] The 70% ethanol elution portion (DO1-D, 7.9 g) of the water extract of the stem of Dendrobium candidum was separated by silica gel column chromatography, and gradient eluted in sequence with a dichloromethane-methanol system (the volume ratio of dichloromethane-methanol was 100:0, 99:1, 98:2, 97:3, 95:5, 93:7, 9:1, 8:2, 7:3, 1:1, 0:100), and each system was eluted with 4 retention volumes, each volume was 100 mL, and combined after thin layer chromatography behavior analysis to obtain a total of 10 fractions (DO1-D1 to DO1-D10). The fraction DO1-D3 (474.2 mg) was obtained at a dichloromethane-methanol volume ratio of 99:1, and the fraction DO1-D4 (391.4 mg) was obtained at a dichloromethane-methanol volume ratio of 98:2.
[0043] DO1-D3 (474.2 mg) was separated and purified by Sephadex LH-20 column chromatography and isocratically eluted with a dichloromethane-methanol system with a volume ratio of 1:1 to obtain fractions DO1-D31 to DO1-D33, among which DO1-D33 (181.0 mg) was separated and purified by ODS column chromatography and gradient eluted with a methanol-water system (the volume percentage of methanol-water was 30%, 40%, 50%, 60%, 70%, and 100%) in sequence, and each system was eluted with 4 retention volumes, each volume was 12 mL. According to the analysis of thin layer chromatography color development behavior, fraction DO1-D332 was obtained in a 40% by volume methanol-water solution. DO1-D332 (79.7 mg) was further separated by preparative high performance liquid chromatography (HPLC) using an ultraviolet detector as the detection means, a wavelength of 240 nm, and a 50% by volume methanol-water solution as the eluent for HPLC preparation. The flow rate was 4 mL / min, and the chromatographic peak was collected for 23 minutes to obtain compound 4 (2.9 mg).
[0044] DO1-D4 (391.4 mg) was separated and purified by Sephadex LH-20 column chromatography and isocratically eluted with a dichloromethane-methanol system with a volume ratio of 1:1 to obtain fractions DO1-D41 to DO1-D42, among which DO1-D42 (153.4 mg) was separated and purified by ODS column chromatography and gradient eluted with a methanol-water system (the volume percentage of methanol-water was 20%, 30%, 40%, 50%, 60%, 70%, and 100%) in sequence, and each system was eluted with 4 retention volumes, each volume was 9 mL. According to the analysis of thin layer chromatography color development behavior, fraction DO1-D425 was obtained in a 60% by volume methanol-water solution. DO1-D425 (8.7 mg) was further separated by preparative high performance liquid chromatography (HPLC) using an ultraviolet detector as the detection means, a wavelength of 220 nm, and a 45% by volume methanol-water solution as the eluent for HPLC preparation. The flow rate was 4 mL / min, and the chromatographic peak was collected for 37 minutes to obtain compound 2 (2.0 mg).
[0045] The 95% ethanol elution portion (DO1-E, 5.0 g) of the water extract of the stem of Dendrobium officinale was separated by silica gel column chromatography, and gradient eluted in sequence with a dichloromethane-methanol system (the volume ratio of dichloromethane-methanol was 100:0, 99:1, 98:2, 93:7, 95:5, 93:7, 9:1, 8:2, 7:3, 1:1, 0:100), and each system was eluted with 4 retention volumes, each volume was 60 mL, and combined after thin layer chromatography behavior analysis to obtain a total of 8 fractions (DO1-E1 to DO1-E8). Fraction DO1-E2 (101.2 mg) was obtained at a dichloromethane-methanol volume ratio of 100:0, and fraction DO1-E4 (1.2 g) was obtained at a dichloromethane-methanol volume ratio of 99:1.
[0046] DO1-E2 (101.2 mg) was separated and purified by Sephadex LH-20 column chromatography and isocratically eluted with a dichloromethane-methanol system with a volume ratio of 1:1 to obtain fractions DO1-E21 to DO1-E23, among which DO1-E23 (47.2 mg) was separated and purified by ODS column chromatography and gradient eluted with a methanol-water system (the volume percentage of methanol-water was 50%, 60%, 70%, 80%, 90%, and 100%) in sequence, and each system was eluted with 4 retention volumes, each volume was 4 mL. According to the analysis of thin layer chromatography color development behavior, fraction DO1-E233 was obtained in a 70% by volume methanol-water solution. DO1-E233 (5.0 mg) was further separated by preparative high performance liquid chromatography (HPLC) using an ultraviolet detector as the detection means, a wavelength of 220 nm, and a 55% by volume methanol-water solution as the eluent for HPLC preparation. The flow rate was 4 mL / min, and the chromatographic peak was collected for 41 minutes to obtain compound 5 (2.0 mg).
[0047] DO1-E4 (1.2 g) was separated and purified by Sephadex LH-20 column chromatography, and isocratically eluted with a dichloromethane-methanol system with a volume ratio of 1:1 to obtain fractions DO1-E41 to DO1-E43, wherein DO1-E42 (548.8 mg) was separated by ODS column chromatography, and gradient eluted with a methanol-water system (methanol-water volume percentage of 40%, 50%, 60%, 70%, 80%, 100%) in sequence, and each system was washed with 4 retention volumes, each volume of 35 mL. According to the analysis of the color behavior of thin layer chromatography, fraction DO1-E421 was obtained in a methanol-water solution with a volume percentage of 40%, fraction DO1-E422 was obtained in a methanol-water solution with a volume percentage of 50%, and fraction DO1-E423 was obtained in a methanol-water solution with a volume percentage of 60%. DO1-E421 (183.5 mg) was further separated by preparative high performance liquid chromatography (HPLC), with an ultraviolet detector as the detection means, a wavelength of 240 nm, and a 50% by volume methanol-water solution as the eluent for HPLC preparation, a flow rate of 4 mL / min, and the chromatographic peak was collected for 22 min to obtain compound 3 (2.0 mg). DO1-E422 (124.8 mg) was further separated by preparative high performance liquid chromatography (HPLC), with an ultraviolet detector as the detection means, a wavelength of 240 nm, and a 60% by volume methanol-water solution as the eluent for HPLC preparation, a flow rate of 4 mL / min, and the chromatographic peak was collected for 20 min to obtain compound 1 (13.8 mg). DO1-E423 (91.6 mg) was further separated by preparative high performance liquid chromatography (HPLC) with an ultraviolet detector as the detection means, a wavelength of 240 nm, and a 55% by volume methanol-water solution as the eluent for HPLC preparation. The flow rate was 4 mL / min, and the chromatographic peak was collected at 43 min to obtain compound 6 (10.2 mg).
[0048] The ethanol extract of Dendrobium officinale stem (DO2, 58.0 g) was separated by silica gel column chromatography and eluted with cyclohexane-ethyl acetate and dichloromethane-methanol gradient (the volume ratio of cyclohexane-ethyl acetate was 100:0, 96:4, 9:1, 85:15, 8:2, 7:3, 6:4, 1:1. The volume ratio of dichloromethane-methanol was 93:7, 9:1, 85:15, 8:2, 7:3, 6:4, 1:1, 0:100). Each system was washed with 4 retention volumes, each volume was 750 mL, and after thin layer chromatography behavior analysis, 15 fractions (DO2-A to DO2-O) were obtained. Fraction DO2-C was obtained at a dichloromethane-methanol volume ratio of 9:1. DO2-C (4.08 g) was separated and purified by Sephadex LH-20 column chromatography, and isocratically eluted with a dichloromethane-methanol system with a volume ratio of 1:1 to obtain fractions DO2-C1 to DO2-C4, of which DO2-C3 (2.46 g) was again separated by silica gel column chromatography, and gradient eluted with a cyclohexane-acetone system (the volume ratio of cyclohexane-acetone was 97:3, 95:5, 93:7, 9:1, 85:15, 0:100) in sequence. According to the thin layer chromatography behavior analysis, a total of 8 fractions (DO2-C31 to DO2-C38) were obtained, and fraction DO2-C35 (143.4 mg) was obtained at a cyclohexane-acetone volume ratio of 93:7.
[0049] DO2-C35 (143.4 mg) was separated by ODS column chromatography, and gradient eluted with methanol-water system (methanol-water volume percentage of 70%, 80%, 90%, 100%) in sequence, and each system was washed with 4 retention volumes, each volume of 8 mL. According to the analysis of thin layer chromatography color behavior, the fraction DO2-C351 was obtained in a methanol-water solution with a volume percentage of 70%, and DO2-C351 (27.4 mg) was further separated by preparative high performance liquid chromatography (HPLC), with an ultraviolet detector as the detection means, a wavelength of 210 nm, and 42% by volume acetonitrile-water solution as the eluent for HPLC preparation, the flow rate was 4 mL / min, and the chromatographic peak was collected for 33 min to obtain compound 7 (5.3 mg).
[0050] Example 3 Structural Identification of Compounds
[0051] The hydrogen spectra of compounds 1 and 2 ( 1 H-NMR) and carbon spectra ( 13 The data of C-NMR are shown in Table 1.
[0052] The hydrogen spectra of compounds 3 and 4 ( 1 H-NMR) and carbon spectra ( 13 The data of C-NMR are shown in Table 2.
[0053] The hydrogen spectra of compounds 5, 6 and 7 ( 1 H-NMR) and carbon spectra ( 13 The data of C-NMR are shown in Table 3.
[0054] Table 1 Compounds 1 and 2 1 H-NMR and 13 C-NMR data (CD3OD)
[0055]
[0056]
[0057] Table 2 Compounds 3 and 4 1 H-NMR and 13 C-NMR data (CD3OD)
[0058]
[0059] Table 3 Compounds 5, 6 and 7 1 H-NMR and 13 C-NMR data (CD3OD)
[0060]
[0061]
[0062] The physicochemical properties of compounds 1 to 7 shown in the present invention are as follows:
[0063] Compound 1 (dendrocandin O)
[0064] Yellow powder, The FeCl3 reaction was positive, indicating the presence of phenolic hydroxyl groups in the structure. ESI-MS (negative) gave m / z 453 [MH] - , its molecular weight is estimated to be 454. 1 H-NMR and 13 C-NMR data confirmed that the molecular formula of the compound is C 25 H 26 O8, its unsaturation is calculated to be 13.
[0065] Compound 2 (dendrocandin N)
[0066] Yellow powder, The FeCl3 reaction was positive, indicating the presence of phenolic hydroxyl groups in the structure. ESI-MS (positive) gave m / z 461 [M+Na] +, ESI-MS (negative) gave m / z 437 [MH] - , its molecular weight is estimated to be 438. 1 H-NMR and 13 C-NMR data confirmed that the molecular formula of the compound is C 25 H 26 O7, its unsaturation is calculated to be 13.
[0067] Compound 3 (3,4'-dihydroxy-5-methoxybibenzyl)
[0068] Yellow oil, FeCl3 reaction is positive, indicating the presence of phenolic hydroxyl groups in the structure. ESI-MS (positive) gives m / z 245 [M+H] + , its molecular weight is estimated to be 244. 1 H-NMR and 13 C-NMR data confirmed that the molecular formula of the compound is C 15 H 16 O3, its unsaturation is calculated to be 8.
[0069] Compound 4 (3,3'-dihydroxy-5-methoxybibenzyl)
[0070] Yellow oil, FeCl3 reaction is positive, indicating the presence of phenolic hydroxyl groups in the structure. ESI-MS (positive) gives m / z 245 [M+H] + ,m / z 267[M+Na] + , its molecular weight is estimated to be 244. 1 H-NMR and 13 C-NMR data confirmed that the molecular formula of the compound is C 15 H 16 O3, its unsaturation is calculated to be 8.
[0071] Compound 5 (3-hydroxy-4',5-dimethoxybibenzyl)
[0072] Yellow oil, FeCl3 reaction is positive, indicating the presence of phenolic hydroxyl groups in the structure. ESI-MS (negative) gives m / z 257 [MH] - , its molecular weight is estimated to be 258. 1 H-NMR and 13 C-NMR data confirmed that the molecular formula of the compound is C 16 H 18 O3, its unsaturation is calculated to be 8.
[0073] Compound 6 (3-hydroxy-3',4',5-trimethoxybibenzyl)
[0074] Yellow oil, FeCl3 reaction is positive, indicating the presence of phenolic hydroxyl groups in the structure. ESI-MS (positive) gives m / z 289 [M+H] + , its molecular weight is estimated to be 288. 1 H-NMR and 13 C-NMR data confirmed that the molecular formula of the compound is C 17 H 20 O4, its unsaturation is calculated to be 8.
[0075] Compound 7 (4'-Hydroxy-3,3',4,5-tetramethoxybibenzyl)
[0076] Colorless oil, FeCl3 reaction positive, indicating the presence of phenolic hydroxyl groups in the structure. ESI-MS (positive) gives m / z 319 [M+H] + ,m / z 341[M+Na] + , ESI-MS (negative) gave m / z 317 [MH] - , its molecular weight is estimated to be 318, combined with 1 H-NMR and 13 C-NMR data confirmed that the molecular formula of the compound is C 18 H 22 O5, its unsaturation is calculated to be 8.
[0077] Example 4 Protective effect of the compound on ethanol-induced damage of human gastric epithelial cells (GES-1 cells)
[0078] (1) Cell passaging and culture: Observe the cells in the culture flask under a microscope. When the cells adhere to about 80% of the bottom of the culture flask, they can be passaged. Discard the original culture medium, add an appropriate amount of PBS solution to wash twice, and discard the PBS. Add an appropriate amount of trypsin and incubate in a 37°C, 5% CO2 cell culture incubator for 5 min. When the cells shrink and fall off, terminate the digestion with DMEM cell culture medium containing 10% FBS fetal bovine serum, blow gently to make the remaining adherent cells fall off, and transfer the cell suspension to a centrifuge tube. Place in a centrifuge and centrifuge at 900 rpm for 5 min, and remove the supernatant. Add an appropriate amount of cell culture medium to resuspend, divide into several bottles, and place in a 37°C, 5% CO2 cell culture incubator for further culture.
[0079] (2) An ethanol-induced GES-1 cell injury model was established. Different concentrations of ethanol were selected to act on GES-1 cells. By comparing the survival rates of GES-1 cells under different concentrations and different time periods, the ethanol concentration (5%) with a cell survival rate of about 40% was selected as the inducing concentration.
[0080] (3) GES-1 cell lines in the logarithmic growth phase were collected and prepared into a cell suspension using the corresponding cell culture medium. 4 135 μL of cell suspension was added to the well plate and the plate was placed in a 37°C, 5% CO2 incubator for about 24 h to allow the cells to adhere to the wall.
[0081] (4) According to the designed drug concentration, add fresh cell culture medium for preparation, administer 15 μL per well, and replicate for each concentration. Add ethanol 2 hours later, with the ethanol concentration in each well being 5%. After 3 hours of ethanol stimulation, add MTT solution. After culturing at 37°C for 4 hours, aspirate the supernatant, add 150 μL of 10% SDS solution to each well, and culture in a 37°C incubator overnight. At the same time, set up a blank control group (only culture medium added) and an ethanol stimulation group (culture medium containing 5% ethanol added). Use an enzyme reader to measure the absorbance value (OD value) of each well at a wavelength of 570 nm. The following formula is used to calculate the survival rate:
[0082] Cell survival rate (%) = (A 空白对照 -A 样品 ) / A 空白对照 ×100%
[0083] Experimental results: The statistical results are shown in Table 4. Compounds 1-7 can significantly increase the survival rate of human gastric mucosal epithelial GES-1 cells damaged by ethanol and have a protective effect on gastric mucosa.
[0084] As attached Figure 2 The figure shows the protective effect of compounds 1 to 4 extracted from the present invention on ethanol-induced damage to human gastric mucosal epithelial cells. Figure 2 It can be seen that compound 3 can increase the survival rate of human gastric epithelial GES-1 cells induced by ethanol at a concentration of 1 μM, and its protective effect increases with the increase of compound 3 concentration in the concentration range of 1 to 100 μM; compound 1 can increase the survival rate of human gastric epithelial GES-1 cells induced by ethanol at a concentration of 10 μM, and its protective effect increases with the increase of compound 1 concentration in the concentration range of 10 to 100 μM; compounds 2 and 4 can increase the survival rate of human gastric epithelial GES-1 cells induced by ethanol at a concentration of 50 μM, and the protective effects of compounds 2 and 4 are more obvious at a concentration of 100 μM.
[0085] As attached Figure 3 The figure shows the protective effect of compounds 5 to 7 extracted from the present invention on ethanol-induced damage to human gastric mucosal epithelial cells. Figure 3It can be seen that compound 5 can significantly increase the survival rate of ethanol-induced human gastric epithelial GES-1 cells at a concentration of 100 μM; compound 6 can increase the survival rate of ethanol-induced human gastric epithelial GES-1 cells at a concentration of 50 μM, and the protective effect of compound 6 is more obvious at a concentration of 100 μM; compound 7 can increase the survival rate of ethanol-induced human gastric epithelial GES-1 cells at a concentration of 10 μM, and the protective effect of compound 7 is more obvious at a concentration of 100 μM.
[0086] Table 4 Protective effect of compounds 1-7 on ethanol-induced damage of human gastric epithelial cells (GES-1 cells)
[0087]
[0088] The bibenzyl compound in the Dendrobium officinale of the present invention can be a medical drug, which can be prepared into oral liquid, capsule, tablet, effervescent tablet, granule or various known dosage forms.
[0089] For any technician familiar with the art, without departing from the scope of the technical solution of the present invention, the technical content disclosed above can be used to make many possible changes and modifications to the technical solution of the present invention, or modified into equivalent embodiments with equivalent changes. Therefore, any simple modification, equivalent change and modification made to the above embodiments according to the technical essence of the present invention without departing from the content of the technical solution of the present invention should still fall within the scope of protection of the technical solution of the present invention.
Claims
1. A method for extracting bibenzyl compounds, characterized in that: The following steps are involved: S1. Extract the stem of Dendrobium officinale with water and concentrate it to obtain a water extract, extract the residue obtained after the water extraction with alcohol and concentrate it to obtain an alcohol extract; first separate the water extract with macroporous adsorption resin column chromatography, perform gradient elution with ethanol-water system, then separate it with silica gel column chromatography, perform gradient elution with dichloromethane-methanol system, and purify it to obtain any one of the following bibenzyl compounds: S2. Separate the alcohol extract by silica gel column chromatography, elute with cyclohexane-ethyl acetate and dichloromethane-methanol gradient, and purify to obtain the following bibenzyl compounds: The method for gradient elution with an ethanol-water system in step S1 includes performing gradient elution with an ethanol-water system having gradient concentrations of 0:100, 30:70, 50:50, 70:30, and 95:5, collecting an eluent having an ethanol-water concentration of 70:30, i.e., DO1-D, and an eluent having an ethanol-water concentration of 95:5, i.e., DO1-E; the method for gradient elution with a dichloromethane-methanol system in step S1 includes eluting DO1 -D and DO1-E were gradient eluted with a dichloromethane-methanol system with a volume ratio of 100:0, 99:1, 98:2, 97:3, 95:5, 93:7, 9:1, 8:2, 7:3, 1:1, and 0:100, and the eluates with a volume ratio of 99:1, i.e. DO1-D3, 98:2, i.e. DO1-D4, 100:0, i.e. DO1-E2, and 99:1, i.e. DO1-E4 were collected respectively; The purification method described in step S1 comprises separating and purifying DO1-D3, DO1-D4, DO1-E2, and DO1-E4 by Sephadex LH-20 column chromatography, isocratically eluting with a dichloromethane-methanol system with a volume ratio of 1:1; separating by ODS column chromatography, gradient eluting with a methanol-water system, and separating by high performance liquid chromatography; The method of gradient elution with a methanol-water system includes gradient elution in sequence according to the volume percentage of the methanol-water system being 20%, 30%, 40%, 50%, 60%, 70%, and 100%; DO1-D3 was dissolved in a 40% by volume methanol-water solution to obtain DO1-D332, and preparative liquid chromatography was performed at an ultraviolet detection wavelength of 240 nm using a 50% by volume methanol-water solution as an eluent at a flow rate of 4 mL / min, and the chromatographic peak was collected for 23 min to obtain a compound of formula (4); DO1-D4 was dissolved in a 60% by volume methanol-water solution to obtain DO1-D425. The preparative liquid chromatography was performed at an ultraviolet detection wavelength of 220 nm using a 45% by volume methanol-water solution as an eluent at a flow rate of 4 mL / min. The chromatographic peak was collected at 37 min to obtain a compound of formula (2); DO1-E2 was dissolved in a 70% by volume methanol-water solution to obtain DO1-E233. The preparative liquid chromatography was performed at an ultraviolet detection wavelength of 220 nm using a 55% by volume methanol-water solution as the eluent at a flow rate of 4 mL / min. The chromatographic peak was collected at 41 min to obtain a compound of formula (5); DO1-E4 was dissolved in a 40% by volume methanol-water solution to obtain DO1-E421. The preparative liquid chromatography was performed at an ultraviolet detection wavelength of 240 nm using a 50% by volume methanol-water solution as an eluent at a flow rate of 4 mL / min. The chromatographic peak was collected for 22 minutes to obtain a compound of formula (3); DO1-E4 was dissolved in a 50% by volume methanol-water solution to obtain DO1-E422. The preparative liquid chromatography was performed at an ultraviolet detection wavelength of 240 nm using a 60% by volume methanol-water solution as an eluent at a flow rate of 4 mL / min. The chromatographic peak was collected for 20 min to obtain a compound of formula (1); DO1-E4 was dissolved in a 60% by volume methanol-water solution to obtain DO1-E423, and HPLC preparation was performed at an ultraviolet detection wavelength of 240 nm using a 55% by volume methanol-water solution as the eluent, at a flow rate of 4 mL / min, and the chromatographic peak was collected at 43 min to obtain a compound of formula (6); In step S2, the volume ratio of cyclohexane to ethyl acetate is 100:0, 96:4, 9:1, 85:15, 8:2, 7:3, 6:4, and 1:1; the volume ratio of dichloromethane to methanol is 93:7, 9:1, 85:15, 8:2, 7:3, 6:4, 1:1, and 0:100, and the eluent with a volume ratio of dichloromethane to methanol of 9:1 is collected, i.e., DO2-C; The purification method described in step S2 comprises separating and purifying DO2-C by Sephadex LH-20 column chromatography, isocratically eluting with a dichloromethane-methanol system with a volume ratio of 1:1; separating by silica gel column chromatography, gradient eluting with a cyclohexane-acetone system, separating by ODS column chromatography, gradient eluting with a methanol-water system, and separating by high performance liquid chromatography; The method for gradient elution with a cyclohexane-acetone system comprises performing gradient elution in sequence according to a volume ratio of 97:3, 95:5, 93:7, 9:1, 85:15, and 0:100 of the cyclohexane-acetone system, and collecting an eluate with a volume ratio of 93:7 of cyclohexane-acetone, i.e., DO2-C35; the method for gradient elution with a methanol-water system comprises performing gradient elution in sequence according to a volume percentage of 70%, 80%, 90%, and 100% of methanol-water, and obtaining DO2-C351 in a methanol-water solution with a volume percentage of 70%; The high performance liquid chromatography separation method comprises subjecting DO2-C351 to preparative liquid chromatography at an ultraviolet detection wavelength of 210 nm, using an acetonitrile-water solution with a volume percentage of 42% as an eluent, a flow rate of 4 mL / min, and collecting a chromatographic peak for 33 minutes to obtain a compound of formula (7).
2. Use of the bibenzyl compound obtained by the extraction method according to claim 1 in the preparation of a drug for treating ethanol-induced human gastric mucosal epithelial cell damage.
Citation Information
Patent Citations
Eye-brightening and health-enhancing vinegar drink and preparation method thereof
WO2017041459A1
